These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

64 related articles for article (PubMed ID: 1218983)

  • 21. Histocompatibility in humans.
    Fotino M
    Ann Clin Lab Sci (1971); 1971; 1(2):125-30. PubMed ID: 4405210
    [No Abstract]   [Full Text] [Related]  

  • 22. Relationship of mixed lymphocyte culture response, HL-A histocompatibility antigens, and renal transplantation.
    Thompson JS; Flink RJ; Caldwell JL; Severson CD; Bonney WW
    Transplant Proc; 1973 Dec; 5(4):1763-9. PubMed ID: 4130081
    [No Abstract]   [Full Text] [Related]  

  • 23. Regulation of B- and T-cell mediated xenogeneic transplant rejection by interleukin 12.
    Hosiawa KA; Wang H; DeVries ME; Garcia B; Jiang J; Zhou D; Cameron MJ; Zhong R; Kelvin DJ
    Transplantation; 2006 Jan; 81(2):265-72. PubMed ID: 16436971
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Current problems of transplantation immunology].
    Kaden J
    Z Arztl Fortbild (Jena); 1974 Jun; 68(12):599-610. PubMed ID: 4139826
    [No Abstract]   [Full Text] [Related]  

  • 25. Genetic control of "in vitro" lymphocyte reactions. New concepts.
    Bach FH
    Biomedicine; 1973 May; 18(3):177-80. PubMed ID: 4270281
    [No Abstract]   [Full Text] [Related]  

  • 26. Proliferating helper-cell (PHC) test: a possible addition to the armamentarium for histocompatibility testing.
    Bach ML; Bach FH
    Transplant Proc; 1973 Dec; 5(4):1755-7. PubMed ID: 4272830
    [No Abstract]   [Full Text] [Related]  

  • 27. T-T cell interactions in cell-mediated immune responses to major histocompatibility complex antigens.
    Rich RR; Rich SS
    Crit Rev Immunol; 1983; 4(2):129-68. PubMed ID: 6221885
    [No Abstract]   [Full Text] [Related]  

  • 28. Role of activated natural killer and CD4+, CD8+ cells in the cellular rejection of a discordant xenograft.
    Elsen M; Soares M; Latinne D; Cornet A; Bazin H
    Transplant Proc; 1993 Feb; 25(1 Pt 1):447-9. PubMed ID: 8438373
    [No Abstract]   [Full Text] [Related]  

  • 29. Temporal reduction in acute rejection after heart transplantation is not associated with a reduction in cell-mediated responses to donor-specific vascular endothelium.
    Hosenpud JD; Shipley GD; Mauck KA; Morris TE; Wagner CR
    J Heart Lung Transplant; 1995; 14(5):926-37. PubMed ID: 8800729
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Histocompatibility matching between humans and baboons.
    Neethling FA; Nortman PJ; Cooper DK
    Transplant Proc; 1990 Jun; 22(3):1067-9. PubMed ID: 2140915
    [No Abstract]   [Full Text] [Related]  

  • 31. Correlation between cellular manifestations of allograft response and graft rejection times.
    Viklický V; Polácková M
    Folia Biol (Praha); 1974; 20(2):125-32. PubMed ID: 4140110
    [No Abstract]   [Full Text] [Related]  

  • 32. Haplotype matching is not an essential requirement to achieve remyelination of demyelinating CNS lesions.
    Tepavcević V; Blakemore WF
    Glia; 2006 Dec; 54(8):880-90. PubMed ID: 17006890
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Different patterns in donor-specific production of T-helper 1 and 2 cytokines by cells infiltrating the rejecting cardiac allograft.
    van Besouw NM; Daane CR; Vaessen LM; Balk AH; Claas FH; Zondervan PE; Jutte NH; Weimar W
    J Heart Lung Transplant; 1995; 14(5):816-23. PubMed ID: 8800715
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Acute rejection of orthotopic corneal xenografts in mice depends on CD4(+) T cells and self-antigen-presenting cells.
    Tanaka K; Sonoda K; Streilein JW
    Invest Ophthalmol Vis Sci; 2001 Nov; 42(12):2878-84. PubMed ID: 11687532
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Immunologic reconstitution in severe combined immunodeficiency with HL-A-incompatible bone marrow graft: donor selection by mixed lymphocyte culture.
    Dupont B; Andersen V; Ernst P; Faber V; Good RA; Hansen GS; Henriksen K; Jensen K; Juhl F; Killmann SA; Koch C; Muller-Berat N; Park BH; Svejgaard A; Thomsen M; Wiik A
    Transplant Proc; 1973 Mar; 5(1):905-8. PubMed ID: 4144470
    [No Abstract]   [Full Text] [Related]  

  • 36. [Immunological diagnosis of the kidney allograft rejection reaction].
    Drannik GN
    Urol Nefrol (Mosk); 1981; (5):64-71. PubMed ID: 6458144
    [No Abstract]   [Full Text] [Related]  

  • 37. Reduction of Foxp3-expressing regulatory T cell infiltrates during the progression of renal allograft rejection in a mouse model.
    Wang S; Jiang J; Guan Q; Lan Z; Wang H; Nguan CY; Jevnikar AM; Du C
    Transpl Immunol; 2008 May; 19(2):93-102. PubMed ID: 18503884
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The inhibitory effects of mouse ICOS-Ig gene-modified mouse dendritic cells on T cells.
    Wang G; Zhu L; Hu P; Zhu H; Lei P; Liao W; Yu B; Gong F; Shen G
    Cell Mol Immunol; 2004 Apr; 1(2):153-7. PubMed ID: 16212904
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Correlation between changes in cellular immunity and rejection in rat small bowel transplantation.
    Wang P; Zhu L; Liu T; He X; Zhu W
    Transplant Proc; 1994 Jun; 26(3):1557. PubMed ID: 7913267
    [No Abstract]   [Full Text] [Related]  

  • 40. Donor-specific T-cell reactivity identifies kidney transplant patients in whom immunosuppressive therapy can be safely reduced.
    van Besouw NM; van der Mast BJ; de Kuiper P; Smak Gregoor PJ; Vaessen LM; IJzermans JN; van Gelder T; Weimar W
    Transplantation; 2000 Jul; 70(1):136-43. PubMed ID: 10919590
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.